Chromosomes humains de la paire 15 : Questions médicales fréquentes
Nom anglais: Chromosomes, Human, Pair 15
Descriptor UI:D002884
Tree Number:G05.360.162.520.300.370.385
Termes MeSH sélectionnés :
Data Interpretation, Statistical
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chromosomes humains de la paire 15 : Questions médicales les plus fréquentes",
"headline": "Chromosomes humains de la paire 15 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chromosomes humains de la paire 15 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-05",
"dateModified": "2025-02-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chromosomes humains de la paire 15"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Chromosomes humains 13-15",
"url": "https://questionsmedicales.fr/mesh/D002901",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes humains 13-15",
"code": {
"@type": "MedicalCode",
"code": "D002901",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.162.520.300.370"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes humains de la paire 15",
"alternateName": "Chromosomes, Human, Pair 15",
"code": {
"@type": "MedicalCode",
"code": "D002884",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Arang Rhie",
"url": "https://questionsmedicales.fr/author/Arang%20Rhie",
"affiliation": {
"@type": "Organization",
"name": "Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA."
}
},
{
"@type": "Person",
"name": "Sergey Koren",
"url": "https://questionsmedicales.fr/author/Sergey%20Koren",
"affiliation": {
"@type": "Organization",
"name": "Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA."
}
},
{
"@type": "Person",
"name": "Erik Garrison",
"url": "https://questionsmedicales.fr/author/Erik%20Garrison",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN, USA."
}
},
{
"@type": "Person",
"name": "Jennifer L Gerton",
"url": "https://questionsmedicales.fr/author/Jennifer%20L%20Gerton",
"affiliation": {
"@type": "Organization",
"name": "Stowers Institute for Medical Research, Kansas City, MO, USA."
}
},
{
"@type": "Person",
"name": "Andrea Guarracino",
"url": "https://questionsmedicales.fr/author/Andrea%20Guarracino",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients.",
"datePublished": "2022-12-21",
"url": "https://questionsmedicales.fr/article/36543828",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41597-022-01669-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Handling Missing Data in COVID-19 Incidence Estimation: Secondary Data Analysis.",
"datePublished": "2024-08-20",
"url": "https://questionsmedicales.fr/article/39166439",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/53719"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bayesian pattern-mixture models for dropout and intermittently missing data in longitudinal data analysis.",
"datePublished": "2023-05-23",
"url": "https://questionsmedicales.fr/article/37221346",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3758/s13428-023-02128-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "A mathematical framework for the statistical interpretation of biological growth models.",
"datePublished": "2024-10-07",
"url": "https://questionsmedicales.fr/article/39384030",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.biosystems.2024.105342"
}
},
{
"@type": "ScholarlyArticle",
"name": "A wide range of missing imputation approaches in longitudinal data: a simulation study and real data analysis.",
"datePublished": "2023-07-06",
"url": "https://questionsmedicales.fr/article/37415114",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12874-023-01968-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Chromosomes",
"item": "https://questionsmedicales.fr/mesh/D002875"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chromosomes de mammifère",
"item": "https://questionsmedicales.fr/mesh/D033481"
},
{
"@type": "ListItem",
"position": 6,
"name": "Chromosomes humains",
"item": "https://questionsmedicales.fr/mesh/D002877"
},
{
"@type": "ListItem",
"position": 7,
"name": "Chromosomes humains 13-15",
"item": "https://questionsmedicales.fr/mesh/D002901"
},
{
"@type": "ListItem",
"position": 8,
"name": "Chromosomes humains de la paire 15",
"item": "https://questionsmedicales.fr/mesh/D002884"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chromosomes humains de la paire 15 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chromosomes humains de la paire 15",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chromosomes humains de la paire 15",
"description": "Comment diagnostiquer une anomalie du chromosome 15 ?\nQuels tests génétiques sont utilisés pour le chromosome 15 ?\nQuels signes cliniques indiquent une anomalie sur le chromosome 15 ?\nPeut-on détecter des anomalies chromosomiques in utero ?\nQuel rôle joue le conseil génétique dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Data+Interpretation,+Statistical&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chromosomes humains de la paire 15",
"description": "Quels symptômes sont associés à la trisomie 15 ?\nComment se manifeste le syndrome de Prader-Willi ?\nQuels troubles sont liés à des anomalies du chromosome 15 ?\nLes anomalies du chromosome 15 affectent-elles le comportement ?\nQuels signes peuvent indiquer un syndrome d'Angelman ?",
"url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Data+Interpretation,+Statistical&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chromosomes humains de la paire 15",
"description": "Peut-on prévenir les anomalies chromosomiques ?\nQuel rôle joue le dépistage prénatal ?\nLes antécédents familiaux influencent-ils le risque ?\nComment le mode de vie peut-il affecter le risque ?\nLes vaccinations influencent-elles les anomalies chromosomiques ?",
"url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Data+Interpretation,+Statistical&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chromosomes humains de la paire 15",
"description": "Quels traitements sont disponibles pour le syndrome d'Angelman ?\nComment gérer les symptômes de la trisomie 15 ?\nY a-t-il des médicaments pour traiter les troubles liés au chromosome 15 ?\nQuel rôle joue la thérapie comportementale ?\nLes interventions précoces sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Data+Interpretation,+Statistical&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chromosomes humains de la paire 15",
"description": "Quelles complications peuvent survenir avec le syndrome d'Angelman ?\nLes anomalies du chromosome 15 peuvent-elles affecter la santé physique ?\nY a-t-il des risques de maladies associées ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Data+Interpretation,+Statistical&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chromosomes humains de la paire 15",
"description": "Quels facteurs augmentent le risque d'anomalies chromosomiques ?\nLe tabagisme influence-t-il le risque d'anomalies ?\nL'exposition à des toxines est-elle un facteur de risque ?\nLes maladies maternelles influencent-elles le risque ?\nLe stress maternel a-t-il un impact sur le risque ?",
"url": "https://questionsmedicales.fr/mesh/D002884?mesh_terms=Data+Interpretation,+Statistical&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie du chromosome 15 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un caryotype ou une analyse génétique peut révéler des anomalies sur le chromosome 15."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques sont utilisés pour le chromosome 15 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'analyse de l'ADN, le séquençage et les tests de microdélétions."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une anomalie sur le chromosome 15 ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des retards de développement, des troubles du comportement ou des malformations peuvent indiquer une anomalie."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des anomalies chromosomiques in utero ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests comme l'amniocentèse peuvent détecter des anomalies chromosomiques in utero."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le conseil génétique dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le conseil génétique aide à comprendre les risques et les implications des anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à la trisomie 15 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des retards de développement, des problèmes d'apprentissage et des malformations."
}
},
{
"@type": "Question",
"name": "Comment se manifeste le syndrome de Prader-Willi ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il se manifeste par une hyperphagie, un retard de développement et des problèmes hormonaux."
}
},
{
"@type": "Question",
"name": "Quels troubles sont liés à des anomalies du chromosome 15 ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles comme l'autisme, le syndrome d'Angelman et le syndrome de Prader-Willi sont liés."
}
},
{
"@type": "Question",
"name": "Les anomalies du chromosome 15 affectent-elles le comportement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des troubles du comportement et des difficultés sociales."
}
},
{
"@type": "Question",
"name": "Quels signes peuvent indiquer un syndrome d'Angelman ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent des troubles de la marche, des rires inappropriés et des retards de langage."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies chromosomiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies ne peuvent pas être prévenues, mais le conseil génétique peut aider."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le dépistage prénatal ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage prénatal permet d'identifier les risques d'anomalies chromosomiques chez le fœtus."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux d'anomalies chromosomiques augmentent le risque pour les descendants."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie peut-il affecter le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut réduire certains risques, mais ne prévient pas toutes les anomalies."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles les anomalies chromosomiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccinations ne sont pas liées aux anomalies chromosomiques et sont sûres."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le syndrome d'Angelman ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie physique, l'orthophonie et des interventions comportementales."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes de la trisomie 15 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut des thérapies éducatives, comportementales et un suivi médical régulier."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments pour traiter les troubles liés au chromosome 15 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour gérer les symptômes comme l'anxiété ou l'hyperactivité."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la thérapie comportementale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à améliorer les compétences sociales et à gérer les comportements difficiles."
}
},
{
"@type": "Question",
"name": "Les interventions précoces sont-elles efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent améliorer le développement et la qualité de vie des enfants affectés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le syndrome d'Angelman ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des problèmes de sommeil, des troubles de l'alimentation et des crises."
}
},
{
"@type": "Question",
"name": "Les anomalies du chromosome 15 peuvent-elles affecter la santé physique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des problèmes de croissance, d'obésité et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies associées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des risques de maladies comme le diabète et des troubles cardiovasculaires peuvent exister."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent réduire la qualité de vie en limitant les activités et en nécessitant des soins constants."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais beaucoup nécessitent un suivi à long terme."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'anomalies chromosomiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge maternel avancé et des antécédents familiaux d'anomalies augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque d'anomalies ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme pendant la grossesse peut augmenter le risque d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines environnementales peut augmenter le risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Les maladies maternelles influencent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies maternelles, comme le diabète, peuvent augmenter le risque d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Le stress maternel a-t-il un impact sur le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un stress élevé pendant la grossesse peut influencer le développement fœtal et le risque d'anomalies."
}
}
]
}
]
}
Anonymization has the potential to foster the sharing of medical data. State-of-the-art methods use mathematical models to modify data to reduce privacy risks. However, the degree of protection must b...
The COVID-19 pandemic has revealed significant challenges in disease forecasting and in developing a public health response, emphasizing the need to manage missing data from various sources in making ...
We aimed to show how handling missing data can affect estimates of the COVID-19 incidence rate (CIR) in different pandemic situations....
This study used data from the COVID-19/SARS-CoV-2 surveillance system at the National Institute of Hygiene and Epidemiology, Vietnam. We separated the available data set into 3 distinct periods: zero ...
Our study examined missing data imputation performance across 3 study time periods: zero COVID-19 (n=3149), transition (n=1290), and new normal (n=9288). Imputation analyses showed that K-nearest neig...
Our study emphasizes the importance of understanding that the specific imputation method used by investigators should be tailored to the specific epidemiological context and data collection environmen...
Valid inference can be drawn from a random-effects model for repeated measures that are incomplete if whether the data are missing or not, known as missingness, is independent of the missing data. Dat...
Biological entities are inherently dynamic. As such, various ecological disciplines use mathematical models to describe temporal evolution. Typically, growth curves are modelled as sigmoids, with the ...
Missing data is a pervasive problem in longitudinal data analysis. Several single-imputation (SI) and multiple-imputation (MI) approaches have been proposed to address this issue. In this study, for t...
Using different simulation scenarios derived from a real data set, we compared the performance of cross, trajectory mean, interpolation, copy-mean, and MI methods (27 approaches) to impute missing lon...
The longitudinal regression tree algorithm outperformed based on the criteria such as MSE, RMSE, and MAD than the linear mixed-effects model (LMM) for analyzing the TCGS and simulated data using the m...
Both SI and MI approaches performed better using the longitudinal regression tree algorithm compared with the parametric longitudinal models. Based on the results from both the real and simulated data...
In randomised controlled trials with efficacy-related primary outcomes, adverse events are collected to monitor potential intervention harms. The analysis of adverse event data is challenging, due to ...
We conducted a methodological scoping review of the literature to identify all existing methods using structures within the data to detect signals for adverse reactions in a trial. Embase, MEDLINE, Sc...
We identified 18 different methods from 14 sources. These were categorised as either Bayesian approaches (n=11), which flagged events based on posterior estimates of treatment effects, or error contro...
We found a large number of analysis methods that use the group structures of adverse events. Continuous methodological developments in this area highlight the growing awareness that better practices a...
The FICUS trial is a cluster-randomized superiority trial to determine the effectiveness of a nurse-led, interprofessional family support intervention (FSI) on the quality of care, family management a...
Ultrasound-guided supraclavicular block (UGSCB) is an emerging technique gaining interest amongst emergency physicians that provides regional anaesthesia to the upper limb to tolerate painful procedur...
SUPERB (SUPraclavicular block for Emergency Reduction versus Bier block) is a prospective open-label non-inferiority randomised controlled trial comparing the effectiveness of UGSCB versus BB for clos...
Primary outcome analysis will be performed using both the intention-to-treat and per-protocol populations. The between-group difference in maximum pain intensity will be assessed using linear regressi...
SUPERB is the first randomised controlled trial to investigate the effectiveness and safety of UGSCB in the ED. The trial has the potential to demonstrate that UGSCB is an alternative safe and effecti...
Globally, violence against children poses substantial health and economic challenges, with estimated costs nearing USD 7 trillion. This prompts the urgent call for effective evidence-based interventio...
This study is a pragmatic, two-arm, cluster-randomised trial in Mwanza, Tanzania's urban and peri-urban areas. Assessments are set for baseline, 1 month post-intervention, and 12 months post-intervent...
Preparations for the trial began in December 2022, including community mobilisation and sensitisation. Rolling recruitment, baseline data collection, and implementation onboarding took place between A...
The trial was registered on the Open Science Framework on 14 March 2023: https://doi.org/10.17605/OSF.IO/T9FXZ . The trial protocol was published in Trials 25, 119 (2024): Baerecke, L., Ornellas, A., ...
Neonatal mortality in India has fallen steadily and was estimated to be 24 per 1000 live births in the year 2017. However, neonatal mortality remains high in rural parts of the country. The Community ...
The CHAMPION2 trial forms one part of a cluster-randomised controlled trial with villages (clusters) randomised to receive either a health (CHAMPION2) or education (STRIPES2) intervention. Villages re...
This update to the published trial protocol gives a detailed plan for the statistical analysis of the CHAMPION2 trial....
Registry of India: CTRI/2019/05/019296. Registered on 23 May 2019. https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=MzExOTg=&Enc=&userName=champion2....